Hyperuricemia is a Risk Factor for One-Year Overall Survival in Elderly Female Patients with Acute Coronary Syndrome

Table 1

Baseline characteristics of patients according to sUA levels.

Parameters	sUA normal (n = 460)	Hyperuricemia (n = 251)
Demographics and medical history
Age, years (median, IQR)	78 (76–80)	78 (76–81)	0.308
Female sex, n (%)	164 (35.7)	109 (43.4)	0.042
Body mass index (median, IQR)	22.8 (20.8–25.0)	23.4 (20.8–26.3)	0.101
Diabetes mellitus, n (%)	138 (30.0)	74 (29.5)	0.885
Hypertension, n (%)	334 (72.6)	202 (80.5)	0.020
Atrial fibrillation, n (%)	43 (9.5)	40 (16.2)	0.008
CKD ≥ 3	17 (3.7)	22 (8.8)	0.005
Stroke, n (%)	70 (15.5)	33 (13.5)	0.481
Previous chest pain, n (%)	299 (65.9)	168 (68.3)	0.514
Previous PCI, n (%)	82 (18.1)	32 (13.0)	0.082
Previous CABG, n (%)	9 (2.0)	4 (1.6)	0.739
Current smoking, n (%)	171 (38.5)	82 (34.2)	0.261
Examination findings
SBP, mmHg (median, IQR)	134 (117–152)	132 (118–152)	0.520
DBP, mmHg (median, IQR)	72 (65–81)	71 (64–80)	0.184
Heart rate, beats/min (median, IQR)	75 (67–84)	76 (68–86)	0.158
Clinical presentation
Severe heart failure, n (%)	203 (44.2)	153 (61.0)	<0.001
STEMI, n (%)	120 (26.1)	62 (24.7)	0.686
NSTE-ACS, n (%)	340 (73.9)	189 (75.3)	0.686

sUA: serum uric acid; IQR: interquartile range; CKD: chronic kidney disease; PCI: percutaneous coronary intervention; CABG: coronary artery bypass graft; SBP: systolic blood pressure; DBP: diastolic blood pressure; STEMI: ST-elevated myocardial infarction; NSTE-ACS: non-ST-elevation acute coronary syndrome.